A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by CASI Pharmaceuticals, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
CASI Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00658671
First received: April 11, 2008
Last updated: June 21, 2012
Last verified: June 2012